AbbVie
A Senior Scientist I in the Analytical R&D organization leads the development of synthetic peptide new chemical entities (NCEs) through preclinical and clinical phases. The role involves independently designing experiments, method development, and generating reproducible data to support drug discovery and development pipelines. Collaborators across Pre-Clinical Safety, Process Chemistry, and Regulatory Affairs are essential partners in advancing these therapeutic candidates.
Headquarters
North Chicago, Illinois, United States
Company Size
10001+ employees
Founded
2013
AbbVie is a global, research-driven biopharmaceutical company that was spun off from Abbott Laboratories in 2013. It develops and commercializes specialty medicines across immunology, oncology, neuroscience, eye care and virology — with Humira historically its flagship product — and has broadened its portfolio through acquisitions (notably Allergan) and strategic collaborations. AbbVie emphasizes a robust R&D pipeline, targeted therapies, and global commercial and manufacturing capabilities. The company focuses on delivering long-term treatment options for complex, chronic and serious diseases.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for AbbVie.
AbbVie didn’t post a salary, so this is our estimate from similar listings.
Senior Scientist I/II, Peptide Early Phase Analytical R&D
AbbVie
Senior Scientist I/II, Peptide Early Phase Analytical R&D
AbbVie
Senior Scientist I, Peptide Early Phase Analytical R&D
AbbVie
R&D Peptide Chemistry -Graduate Intern
Amgen
Organic and Conjugation Chemist
Amgen
Scientist II, Analytical Chemistry
pharmaron